CSafe Global has secured approval from European Aviation Safety Agency (EASA) for its new RAP active temperature-controlled container.
The approval allows the firm to offer the new CSafe RAP ULD container for pharmaceutical and life-science companies to ship their temperature-sensitive products globally.
The container expands the company's full line of active and passive cold chain packaging solutions.
CSafe Global president and CEO Brian Kohr said: “The EASA approval of our new active RAP system is very important in our mission to provide cold chain solutions that ensure successful delivery of life-enhancing products around the world.
“With this approval, we mark another important milestone in the launch of the CSafe RAP, providing life-science shippers with a new temperature-controlled container solution, for larger cargo payloads, that is based on our proven system designs and technologies that have been used in successful shipments with the CSafe RKN active container over the past 10 years.”
Designed specifically to meet the growing need for pharmaceutical and life-science companies to ship in larger quantities, the CSafe RAP features heating and compressor-driven cooling technologies.
Additional features of the container include advanced ThermoCor VIP insulation to eliminate the risks to payloads associated with extreme ambient temperature conditions and long-duration shipments.
The new CSafe RAP active container system has the capacity to maintain constant payload temperatures even at extreme ambient temperatures from -30°C to +54°C.
Capable of accommodating up to four standard US-pallets or five standard Euro-pallets, the container has a max payload volume of 6.68m3 with an extended battery life well over 100hrs.
Image: The CSafe’s Global RAP temperature-controlled container. Photo: courtesy of CSafe.